{"filing":{"accession_number":"0001040130-26-000057","cik":"0001040130","ticker":"PETS","company_name":"PETMED EXPRESS INC","form":"8-K","filing_date":"2026-09-28","report_date":"2026-09-27","primary_document":"pets-20260927.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1040130/000104013026000057/pets-20260927.htm"},"events":[{"id":35470,"run_id":32670,"accession_number":"0001040130-26-000057","anchor_item_number":"5.02","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"summary":"The disclosure centers on Board approval of an amendment to the 2024 Inducement Incentive Plan to increase reserved shares by 500,000 specifically to accommodate equity grants (250,000 restricted stock plus 250,000 performance share units) to Jeffrey Allen Willard, the new Chief Executive Officer, as part of his employment agreement. This is a compensatory arrangement for a named executive officer, fitting the exec_compensation category under Item 5.02(e), distinct from the appointment itself (which was disclosed separately on September 17, 2026).","company_name":"PETMED EXPRESS INC","ticker":"PETS","filing_date":"2026-09-28","form":"8-K","submitted_at":null,"items":[{"id":39530,"accession_number":"0001040130-26-000057","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on Board approval of an amendment to the 2024 Inducement Incentive Plan to increase reserved shares by 500,000 specifically to accommodate equity grants (250,000 restricted stock plus 250,000 performance share units) to Jeffrey Allen Willard, the new Chief Executive Officer, as part of his employment agreement. This is a compensatory arrangement for a named executive officer, fitting the exec_compensation category under Item 5.02(e), distinct from the appointment itself (which was disclosed separately on September 17, 2026).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-28T20:31:50.825348+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":39530,"accession_number":"0001040130-26-000057","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on Board approval of an amendment to the 2024 Inducement Incentive Plan to increase reserved shares by 500,000 specifically to accommodate equity grants (250,000 restricted stock plus 250,000 performance share units) to Jeffrey Allen Willard, the new Chief Executive Officer, as part of his employment agreement. This is a compensatory arrangement for a named executive officer, fitting the exec_compensation category under Item 5.02(e), distinct from the appointment itself (which was disclosed separately on September 17, 2026).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-28T20:31:50.825348+00:00","company_name":"PETMED EXPRESS INC","ticker":"PETS","filing_date":"2026-09-28"}]}